Intersect Ent Inc
NASDAQ:XENT
Intersect Ent Inc
EPS (Diluted)
Intersect Ent Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Intersect Ent Inc
NASDAQ:XENT
|
EPS (Diluted)
-$4
|
CAGR 3-Years
-78%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
EPS (Diluted)
$4
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
105%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
33%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
0%
|
CAGR 5-Years
17%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$5
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Intersect Ent Inc's EPS (Diluted)?
EPS (Diluted)
-5
USD
Based on the financial report for Mar 31, 2022, Intersect Ent Inc's EPS (Diluted) amounts to -5 USD.
What is Intersect Ent Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-43%
Over the last year, the EPS (Diluted) growth was -120%. The average annual EPS (Diluted) growth rates for Intersect Ent Inc have been -78% over the past three years , -43% over the past five years .